medigraphic.com

2015, Number 1

<< Back Next >>

Cuba y Salud 2015; 10 (1)

Contributions to pain pathogeny: an approach from the Neuroimmunoendocrinology

León TEJ, Alerm GA, González PU

Language: Spanish
References: 31
Page: 40-45
PDF size: 381.66 Kb.


ABSTRACT

Objetive: The pain is a very important health problem and a subject whose study is increasing. Nonetheless, recent studies show that only 15% of primary care physicians feel capable to treat the chronic pain; and neurons are not only the ones involved in the pain establishment and maintenance. The present study was carried out aiming at evaluating the contribution of the neurological, immune and endocrine systems to the pain pathogeny, in the updated scientif ic literature.
Method: The presence of inflammation in the place damaged causes a sequence of events that produces the concentration and activation of innate immune cells; the production of pro inflammatory cytokines, hormonal and neurotrophic activating factors of glia cells which at the same time disturb the synaptic transmission. All these facts favor the pain persistence.
Conclusions: The interaction of the neurological, immune and endocrine systems in the mechanisms of pain establishment and persistence is unquestionable in the face of the latest scientific findings. Comprehensive modulation of these agents would make available new effective alternatives in the pain management.


REFERENCES

  1. Mogil JS. Animal models of pain: progress and challenges. Nature Reviews Neuroscience 2009;10:283-294.

  2. Chapman CR, Tuckett RP, Song CW. Pain and Stress in a Systems Perspective. Reciprocal Neural, Endocrine and Immune Interactions. J Pain. 2008 February;9(2):122–145.

  3. Fields RD. New culprits in chronic pain. Scientific American. 2009 November; 301(5):50 – 57.

  4. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience. 2007 November;10(11):1361-8.

  5. White FA, Bhangoo SK, Miller RJ. Chemokines: integrators of pain and inflammation. Nature Reviews Drug Discovery. 2005 October;4:834-844.

  6. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nature Immunology. 2011;12:1035–1044.

  7. Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163 -173.

  8. Alexander JK, DeVries AC, Kigerl KA, Dahlman JM, Popovich PG. Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun. 2009;23:851–860.

  9. Fischer TZ, Waxman SG. Neuropathic pain in diabetes - evidence for a central mechanism. Nat Rev Neurol. 2010 July;6(8):462-6.

  10. Tracey KJ. Reflex control of immunity. Nature Reviews Immunology. 2009 June;9:418-28.

  11. Bedoya SK, Lam B, Lau K, Larkin J 3rd. Th17 cells in immunity and autoimmunity. Clin Dev Immunol. 2013;2013:986789.

  12. Urgelles L. Dolor vs. Inflamación: nuevas ideas sobre su evaluación y control. Revista Dolor. 2010;7(V):versión on line. Fecha de consulta: 16 de agosto de 2014. Disponible en: http://www.intramed.net/UserFiles/pdf/68545.pdf

  13. Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol. 2011;6:275–297.

  14. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245–257.

  15. Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract. 2010 May- Jun;10(3):167-84.

  16. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immunelike glial cells and cytokines. Journal of neuroimmunology. 2010;229:26–50.

  17. Graziottin A, Skaper SD, Fusco M. Mast cells in chronic inflammation, pelvic pain and depression in women. Gynecol Endocrinol. 2014 Jul;30(7):472-7.

  18. Schomberg D, Olson JK. Immune responses of microglia in the spinal cord: contribution to pain states. Exp Neurol. 2012 Apr;234(2):262-70.

  19. Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev. 2014 Mar;13(3):242-65.

  20. Chiu IM, Heesters BA, Ghasemlou N, Von Hehn CA, Zhao F, Tran J, et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 2013 Sep 5;501(7465):52–57.

  21. Nicotra L, Loram LC, Watkins LR, Hutchinson MR. Toll-Like Receptors in Chronic Pain. Exp Neurol. 2012 Apr;234(2):316–329.

  22. Chen MC, Meckfessel MH. Autoinflammatory disorders, pain, and neural regulation of inflammation. Dermatol Clin. 2013 Jul;31(3):461- 70.

  23. Guillot X, Semerano L, Decker P, Falgarone G, Boissier MC. Pain and immunity. Joint Bone Spine. 2012 May;79(3):228-36.

  24. Sofat N, Kuttapitiya A. Future directions for the management of pain in osteoarthritis. Int J Rheumatol. 2014 Apr;9(2):197–276.

  25. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30:16–34.

  26. Liu T, Gao YJ, Ji RR. Emerging roles of toll-like receptors in the control of pain and itch. Neurosci Bull. 2012;28:131–44.

  27. Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010;6:191–197.

  28. Boué J, Blanpied C, Djata-Cabral M, Pelletier L, Vergnolle N, Dietrich G. Immune conditions associated with CD4+ T effector-induced opioid release and analgesia. Pain. 2012 Feb;153(2):485-93.

  29. Coaccioli S, Di Cato L, Panaccione A, Crapa ME, Paladini A, Piroli A, et al. Hydromorphone does not influence the immune response in patients affected by chronic pain. Clin Ter. 2013;164(2):e97-9.

  30. Sacerdote P, Franchi S, Panerai AE. Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. Curr Pharm Des. 2012;18(37):6034-42.

  31. Ninković J, Roy S. Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids. 2013 Jul;45(1):9-24.




2020     |     www.medigraphic.com